Madrigal Pharmaceuticals Congress Trades
NASDAQ: MDGLHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Last 12 months
- Purchases
- 0
- Sales
- 0
- Politicians trading
- 0
- Latest trade
- May 12, 2025
Madrigal Pharmaceuticals Congress trading summary
Members of Congress have disclosed 3 transactions in Madrigal Pharmaceuticals (MDGL) stock, reported by 2 politicians. No MDGL trades were reported with a transaction date in the past 12 months. The most active traders are Donald J. Trump (2), Rep. Daniel S. Goldman (1).
The latest reported trade is a sale by Donald J. Trump dated May 12, 2025 and disclosed on Jul 1, 2026. The most common reported amount is $1,001 – $15,000; disclosures list value ranges, not exact amounts.
Summary generated from market data by MetaCap's automated system. Methodology
Politicians trading MDGL
MDGL trades by members of Congress
| Politician | Type | Amount | Traded | Filing |
|---|---|---|---|---|
 Donald J. TrumpRExecutive | Sell | $1,001 – $15,000 | May 12, 2025 | Filing for Donald J. Trump MDGL trade |
| Donald J. TrumpRExecutive | Buy | $1,001 – $15,000 | Apr 11, 2025 | Filing for Donald J. Trump MDGL trade |
 Daniel S. GoldmanD-NYHouse | Sell | $1,001 – $15,000 | Apr 10, 2023 | Filing for Daniel S. Goldman MDGL trade |
Source: House Clerk and Senate EFD public disclosures. Trades are reported as dollar ranges and may be disclosed up to 45 days after the transaction.
Related
Source: House Clerk and Senate EFD public disclosures. Trades are reported as dollar ranges and may be disclosed up to 45 days after the transaction. Disclosures are shown as filed and are not a recommendation to buy or sell MDGL. How Congress trading data works